header image

With a dedicated and long-standing commitment to discovering, developing and manufacturing plasma-derived biopharmaceuticals, Octapharma has unparalleled experience in ensuring these products are brought to market with the highest standards of quality and patient safety.


Our product portfolio is centred in three therapeutic areas. Across these three areas we are able to provide confidence and peace of mind to both Canadian healthcare professionals and the patients whom they treat.

Uniquely beneficial coagulation factors to effectively treat bleeding disorders.

Plasma proteins used to stabilize blood circulation and restore coagulation function.

Immunoglobulins to treat a variety of immunity related disorders.